Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
نویسندگان
چکیده
منابع مشابه
LDL pattern and correlation between LDL size and HDL-C, Triglyceride in type II diabetic patients compared with normal individuals
Introduction: Low density lipoprotein particles are non homogenous in terms of their density and composition. Type B pattern is characterized by predominance of small dense LDL particles. Investigations indicate that small dense LDL is associated with an increased risk of coronary artery disease (CAD). This study is designed to recognize additional effective parameter which could perhaps cont...
متن کاملUnmet Needs in LDL-C Lowering: When Statins Won’t Do!
The use of low-density lipoprotein cholesterol (LDL-C)-lowering medications has led to a significant reduction of cardiovascular risk in both primary and secondary prevention. Statin therapy, one of the cornerstones for the prevention and treatment of cardiovascular disease (CVD), has been demonstrated to be effective in lowering LDL-C levels and in reducing the risk for CVD and is generally we...
متن کاملHigh Blood Pressure, FBS and LDL-C among Diabetic Iranians
Introduction: Control of blood pressure, fasting plasma sugar (FPS) and low-density lipoprotein-cholesterol (LDL-C) reduces to vascular complications of diabetes. In this study we determined the prevalence of diabetic individuals with uncontrolled blood pressure, FPS and LDL-C. Materials and Methods: We used data from three national Surveys of Risk Factors of Non-Communicable Disease (SuRFNCD) ...
متن کاملAssociation between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
BACKGROUND Previous reports have inferred a linear relationship between LDL-C and changes in coronary plaque volume (CPV) measured by intravascular ultrasound. However, these publications included a small number of studies and did not explore other lipid markers. OBJECTIVE To assess the association between changes in lipid markers and regression of CPV using published data. METHODS We colle...
متن کاملIndividualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
Cardiovascular disease remains the leading cause of death in the world. A significant amount of clinical data are available to demonstrate the positive influence that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy has on slowing the progression of cardiovascular disease and improving clinical outcomes. Achieving the treatment goals for cholesterol in cardiovascular d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2018
ISSN: 0098-7484
DOI: 10.1001/jama.2018.2525